PhaseBio Pharmaceuticals Inc
We are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
$12.00 - $14.00
Citigroup, Cowen, Stifel, Needham & Company
To view the prospectus for PhaseBio Pharmaceuticals Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277